Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Cell Biochemistry and Biophysics|May 31, 2022
Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer TherapyXylia Q Peters, Clement Agoni, Mahmoud E S SolimanJournal of Molecular Modeling|May 9, 2020
Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?Clement Agoni, Fisayo A Olotu, Pritika Ramharack, et al.Cell Biochemistry and Biophysics|June 7, 2020
An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline?Fisayo Olotu, Clement Agoni, Opeyemi Soremekun, et al.Scientific Reports|June 28, 2022
Repurposing antiviral phytochemicals from the leaf extracts of Spondias mombin (Linn) towards the identification of potential SARSCOV-2 inhibitorsAkwasi Boadu, Clement Agoni, Rajshekhar Karpoormath, et al.Cell Biochemistry and Biophysics|December 14, 2019
Human Rhinovirus Inhibition Through Capsid "Canyon" Perturbation: Structural Insights into The Role of a Novel Benzothiophene DerivativeClement Agoni, Pritika Ramharack, Geraldene Munsamy, et al.The Protein Journal|February 23, 2020
The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural PerspectivesClement Agoni, Pritika Ramharack, Elliasu Y Salifu, et al.Medical Hypotheses|August 7, 2019
Broadening the horizon: Integrative pharmacophore-based and cheminformatics screening of novel chemical modulators of mitochondria ATP synthase towards interventive Alzheimer's disease therapyIwuchukwu A Emmanuel, Fisayo Olotu, Clement Agoni, et al.Expert Opinion on Drug Discovery|July 22, 2020
The recent application of 3D-QSAR and docking studies to novel HIV-protease inhibitor drug discoveryFisayo A Olotu, Clement Agoni, Opeyemi Soremekun, et al.Future Medicinal Chemistry|September 14, 2019
'Piperazining' the catalytic gatekeepers: unraveling the pan-inhibition of SRC kinases; LYN, FYN and BLK by masitinibAimen K Aljoundi, Clement Agoni, Fisayo A Olotu, et al.Chemistry & Biodiversity|October 6, 2018
Exploring the C-Terminal Tail Dynamics: Structural and Molecular Perspectives into the Therapeutic Activities of Novel CRMP-2 Inhibitors, Naringenin and Naringenin-7-O-glucuronide, in the Treatment of Alzheimer's DiseaseMaryam F Lawal, Fisayo A Olotu, Clement Agoni, et al.Pageof 7